University of Oklahoma Health Sciences Center (OUHSC)

Oklahoma City, Oklahoma 73104-5417

2 studies enrolling now · 5 studies all time

What they study most

Alport Syndrome, Focal Segmental Glomerulosclerosis, Idiopathic Pulmonary Fibrosis (IPF), IgA Vasculitis, Immunoglobulin A Nephropathy, Minimal Change Disease, Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations, SARS-CoV-2 Infection, SARS-CoV2 Infection

Studies at this site

• Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases — Recruiting now
• Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis — Recruiting now
• Understanding the Long-term Impact of COVID on Children and Families — Running, not enrolling
• Understanding the Long-term Impact of COVID-19 in Adults (RECOVER) — Completed
• Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations — Completed